Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

IBIE vs IBIG: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

IBIE Wins Head-to-Head Institutional Verdict (0–0 across 6 Pillars · 3–0 Matrix Metrics)

IBIE Overall Winner 6-Pillar Tally: IBIE 0 – 0 IBIG (6 Tie) Matrix Metrics: IBIE 3 – 0 IBIG

As of Nov 16, 2026, iShares iBonds Oct 2028 Term TIPS ETF (IBIE) is the stronger overall head-to-head candidate over iShares iBonds Oct 2030 Term TIPS ETF (IBIG) in the Tradestie Institutional Equity Comparison Engine, winning 3–0 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). IBIE carries a Unified Composite Score of 55.8/100 (HOLD) at $25.66 (N/M Forward P/E, N/A operating margin), whereas IBIG carries 48.0/100 (HOLD) at $25.14 (N/M Forward P/E, N/A operating margin).

  • Technical & Structure Timing Caution: IBIE is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 43.6); meanwhile IBIG is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 36.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About IBIE vs IBIG
IBIE NYSE Arca Head-to-Head Winner
iShares iBonds Oct 2028 Term TIPS ETF
Institutional Equity
$25.66
+0.0% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.00β · 2% Vol
Unified Composite Score
55.8 / 100 HOLD
Tech 69.0 Fund 55.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -0.1%) with fading momentum, RSI 44
RSI-14: 43.6 · SMA20: $25.73 · SMA50: $25.69
IBIG NYSE Arca
iShares iBonds Oct 2030 Term TIPS ETF
Institutional Equity
$25.14
-0.08% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.04β · 3% Vol
Unified Composite Score
48.0 / 100 HOLD
Tech 48.0 Fund 52.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -0.5%) with fading momentum, RSI 37
RSI-14: 36.8 · SMA20: $25.33 · SMA50: $25.27

6-Pillar Scorecard Institutional Category Breakdown (IBIE 0 – 0 IBIG)

Columns: Metric · IBIE · IBIG
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale Tie
Revenue Growth (YoY) N/A N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A N/A
Market Cap N/A N/A
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin N/A N/A
Net Profit Margin N/A N/A
Return on Equity (ROE) N/A N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Distribution NEUTRAL · Distribution
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: IBIE (3) vs IBIG (0)
Institutional Metric IBIE IBIG Criterion Row Edge
Market Capitalization
Scale
N/A N/A Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A N/A Higher Growth Tie
Operating Margin (TTM)
Profitability
N/A N/A Higher Margin Tie
Net Profit Margin
Profitability
N/A N/A Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
N/A N/A Higher ROE Tie
52-Week Range Position
Momentum
13% ($26–$26) 9% ($25–$27) Stronger Trend IBIE
Beta / 30D Volatility
Risk Regime
0.00β · 2% Vol 0.04β · 3% Vol Lower Realized Risk IBIE
Unified Institutional Score
Composite Signal
55.8 / 100 (HOLD) 48.0 / 100 (HOLD) Higher Composite IBIE
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon IBIE +0.41 pp
IBIE: -0.18% · IBIG: -0.59%
3M Horizon IBIE +1.72 pp
IBIE: -0.42% · IBIG: -2.14%
6M Horizon IBIE +1.89 pp
IBIE: -2.82% · IBIG: -4.71%
1Y Horizon IBIE +2.88 pp
IBIE: -2.04% · IBIG: -4.92%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IBIE vs IBIG. Trailing 12-month operating profitability (IBIE N/A vs IBIG N/A) and valuation multiples (IBIE N/M vs IBIG N/M Forward P/E) are benchmarked directly in Pillar 4 below.

IBIE ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
IBIG ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
IBIE UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact IBIE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
IBIG UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact IBIG Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
IBIE Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
IBIG Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ IBIE vs IBIG Key Questions & Quantitative Answers

As of Nov 16, 2026, iShares iBonds Oct 2028 Term TIPS ETF (IBIE) is the stronger overall head-to-head candidate over iShares iBonds Oct 2030 Term TIPS ETF (IBIG) in the Tradestie Institutional Equity Comparison Engine, winning 3–0 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). IBIE carries a Unified Composite Score of 55.8/100 (HOLD) at $25.66 (N/M Forward P/E, N/A operating margin), whereas IBIG carries 48.0/100 (HOLD) at $25.14 (N/M Forward P/E, N/A operating margin). Technical & Structure Timing Caution: IBIE is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 43.6); meanwhile IBIG is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 36.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

IBIE and IBIG split Growth & Scale metrics: IBIE posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with IBIG at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, IBIE generates N/A in USD-normalized revenue versus N/A for IBIG. In operating R&D and SG&A reinvestment, IBIE deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for IBIG.

IBIE and IBIG trade at balanced relative valuation multiples. IBIE trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas IBIG trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against IBIE (N/A ROE) versus IBIG (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, IBIE carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.00β · 2% Vol realized risk). By comparison, IBIG carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.04β · 3% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.